Black Friday Sale - 20% off Storewide! Free Express shipping on all orders $100+ | Australia Wide Same day dispatch on orders before 12pm
Black Friday Sale - 20% off Storewide! Free Express shipping on all orders $100+ | Australia Wide Same day dispatch on orders before 12pm
Topic guide

Cosmetic Peptides Australia: Powder vs Serum vs Topical

Research powder, cosmetic serum and compounded preparation are three different product classes. What the GHK-Cu topical and parenteral literature actually used.

Research powder vs cosmetic serum

Research powder Cosmetic serum
Product class Laboratory material Finished cosmetic
The number on it Mass in mg, plus batch purity A percentage of the formula
Formulation None, compound only Vehicle, preservatives, chelators
Concentration set by You, at reconstitution The formulator
Supplied by PhaseOne Yes No

The cosmetic peptide category throws up more format confusion than any other, because the same ingredient name appears on three completely different things. A sealed vial of lyophilised research powder, a bottle of serum off a shelf, and a preparation made up by a compounding pharmacy are not interchangeable, and a figure from one does not translate to another.

This guide covers those three formats and what separates them, what the GHK-Cu literature actually used in dermal versus animal work, why a serum percentage will not compare against a vial concentration, and how the compounds in the category differ by mechanism. PhaseOne supplies research powder, and nothing here is guidance on applying or administering anything to a person.

Key points at a glance

  • Research-grade powder, a retail cosmetic serum and a compounded preparation are three separate product classes, regulated differently and not substitutes for each other
  • PhaseOne supplies lyophilised research powder in sealed vials, for laboratory research only
  • A percentage on a serum label and a mg per ml figure from a reconstituted vial are different measurements and cannot be compared directly
  • The GHK-Cu literature splits into dermal and cell-culture work on one side and animal parenteral work on the other, using different preparations and different units
  • Neither literature converts into an amount for a person, and we do not publish administration guidance
  • GHK-Cu and Melanotan II are grouped together by category convention only. They share no receptor or pathway
  • GHK-Cu is the light-sensitive one in this category, because the copper complex is the fragile part

Three formats, one ingredient name

Most of the confusion in this category comes from the word GHK-Cu appearing on products that have almost nothing else in common.

Same ingredient name on all three. Different product classes, different rules, different numbers.
FormatWhat it isWho it comes from
Research powderLyophilised compound in a sealed vial, stated mass, batch HPLC testedA research supplier, for laboratory use
Cosmetic serumA finished formulation with preservatives and a percentage on the labelA cosmetics retailer
Compounded preparationMade up for one named person against a prescriptionA compounding pharmacy, via a prescriber

PhaseOne sits in the first column only. We supply GHK-Cu as research powder and have no cosmetic or compounded line. The practical consequence is that a number from our label, such as 50mg in a vial, is not comparable to a percentage on a serum bottle, and neither of them is a dose.

Research powder, cosmetic serum and compounded preparation

Research powder versus a copper peptide serum

A copper peptide serum is a cosmetic product. It has been formulated: the peptide sits in a vehicle alongside preservatives, chelators, humectants and whatever else the formulator chose, at a concentration the formulator decided, with stability engineered around that mix.

Research powder is the opposite. It is the compound, dry, in a known mass, with a batch purity figure behind it and nothing else in the vial. That makes it the right material for a controlled experiment and the wrong material to treat as a finished product, because every variable a serum has already settled is still open.

The GHK-Cu research guide goes into the mechanism and the copper chemistry. The point for format purposes is narrower: buying research powder does not get you a cheaper serum, and the two cannot be reasoned about with the same numbers.

Topical GHK-Cu: what the research used

Searches for topical GHK-Cu are usually asking whether the skin route is the simple option. The honest answer has two halves, and only one of them is about chemistry.

On the research side: a large part of the GHK-Cu literature is in cell culture and skin models, where the compound is presented in a vehicle at a stated concentration. Those studies establish what happens at the cells, under conditions the experimenter controlled. What they do not establish is how much of an applied amount crosses intact human skin, in what state, from an arbitrary preparation. Skin is a barrier, the copper complex is the fragile part of the molecule, and a vehicle that was never designed for delivery is not a delivery system.

On the practical side: we supply research powder and do not provide instructions for applying anything to a person. If the question is about using a copper peptide on skin, the product class designed and regulated for that is a cosmetic serum from a cosmetics retailer, not laboratory material from us. See the peptide legality guide for why that distinction matters beyond chemistry.

Dermal and parenteral literatures use different preparations

Parenteral routes in the literature

The other half of the GHK-Cu literature is animal work where the compound was given parenterally and dosed by body weight. Searches around GHK-Cu injection usually have this half in mind, or are reasoning backwards from what other research peptides are known for.

Three things are worth being clear about. These are animal studies, with doses expressed per kilogram of animal, in models chosen for the research question rather than to resemble human use. A figure from them does not convert into a human amount, and the arithmetic that looks like it should work does not. And the route used in a study is a feature of the experimental design, not a recommendation carried forward to anybody.

We do not publish administration guidance, dosing schedules or route recommendations for any compound in the range, in this category or any other. Our material ships as powder with a purity figure, and where the compound goes after that is governed by the researcher's own protocol and, if a person is involved, by a prescriber rather than by us.

Why a serum percentage will not compare

This trips up more comparisons than anything else in the category, and it is worth spelling out because the two numbers look superficially similar.

Serum labelReconstituted vial
The numberA percentage, such as 1% or 3%A mass per volume, such as 10mg per ml
What it measuresShare of the total formulationCompound mass in the liquid
Who sets itThe formulatorYou, by how much water you add
Purity behind itNot usually statedBatch HPLC figure
Tells you the delivered amountNoNo, it tells you the concentration

So a 1% serum and a 10mg per ml reconstituted vial are not two points on one scale. One is a share of a mixture and the other is a concentration you chose. Neither is a delivered amount, and converting between them produces a number that means nothing. The reconstitution guide covers how vial concentration is actually set.

A serum percentage and a vial concentration are different measurements

Both sit in this category by convention, and they have no mechanism in common. GHK-Cu is a copper-binding tripeptide whose activity depends on the copper coordination. Melanotan II is a synthetic cyclic analogue of alpha-MSH studied for melanocortin receptor agonism.

GHK-CuMelanotan II
ClassCopper-binding tripeptideCyclic alpha-MSH analogue
Studied atCopper-dependent signallingMC1R and MC4R
Formats in the wildPowder, serum, compoundedPowder, compounded
Poisons StandardNo entrySchedule 4
Light sensitiveYes, the copper complexNot the defining concern

The second row is the one that matters for reading research. A finding about one says nothing about the other, and Melanotan II's MC4R activity is a separate dimension again, unrelated to any pigmentation question. Note also the fourth row: the two compounds are not in the same regulatory position either, which the legality guide covers.

The GLOW and KLOW blends

Both blends are built on GHK-Cu alongside regenerative-category compounds, in one vial.

BlendComponentsVial
GLOWBPC-157, TB-500, GHK-Cu70mg
KLOWBPC-157, TB-500, GHK-Cu, KPV80mg

A blend is a convenience for a protocol that genuinely wants the components together, and a complication for one that does not, because an outcome cannot be attributed to any single component. See the GLOW guide and the KLOW guide , or the regenerative peptide guide for the other compounds in them.

Handling: the copper complex is the fragile part

GHK-Cu is the compound in this category with a real handling constraint, and it comes from the chemistry rather than from the peptide being delicate. The activity depends on copper staying coordinated to the tripeptide, and that complex is light sensitive.

Keep sealed vials dark and refrigerated, keep reconstituted solution dark, and do not leave it sitting on a bench under light. The storage guide has the detail, and the bacteriostatic water guide covers what to reconstitute with.

What the research does not establish

The cosmetic category carries the same evidential gap as the rest of the research peptide space, and in some respects a wider one, because cosmetic claims are easy to make and hard to test.

The literature is concentrated in cell culture, skin models and animal studies. Human clinical evidence is limited. Nothing in it establishes an outcome for a person from an arbitrary preparation at an arbitrary amount by an arbitrary route, which is the gap most cosmetic peptide marketing quietly steps over.

Common misconceptions

That research powder is a cheaper version of a serum. It is a different product class. The serum has solved formulation, stability and delivery; the powder has not, because it was never meant to.

That a percentage and a mg per ml figure are comparable. They measure different things and converting between them produces a meaningless number.

That a dermal study concentration tells you what reaches the skin. It tells you the concentration in the vehicle the experimenter used, under conditions they controlled.

That an animal dose per kilogram scales to a person. It does not, and treating it as arithmetic is the most common error in this whole subject.

That GHK-Cu and Melanotan II are variations on a theme because they are sold alongside each other. They share no receptor, no pathway and not even the same regulatory status.

Verifying purity in this category

Every PhaseOne batch in the cosmetic category is tested by an independent laboratory using HPLC against a purity standard of ≥99%, and the result is published in the public COA library rather than enclosed with a vial or supplied on request.

Purity matters more than usual for GHK-Cu, because the figure is about the complex rather than a bare peptide chain, and because it is one of the few numbers in this category that means something precise. See the HPLC standards guide for how to read a certificate.

For the compound itself, see the GHK-Cu research guide and the Melanotan II guide . For the blends, see GLOW and KLOW . For regulatory position, see the peptide legality guide . For handling, see the reconstitution guide and the storage guide .

Frequently Asked Questions

Is topical GHK-Cu the same as research-grade GHK-Cu?

No. A topical product is a formulated cosmetic with a vehicle, preservatives and a stated percentage. Research-grade GHK-Cu is dry powder in a sealed vial with a batch purity figure and nothing else in it.

Can I use research powder topically?

We supply it for laboratory research and do not provide instructions for applying anything to a person. If the goal is a copper peptide on skin, a cosmetic serum from a cosmetics retailer is the product class designed and regulated for that.

What does the topical GHK-Cu research actually show?

Cell culture and skin-model studies show effects at the cells at concentrations the experimenter controlled. They do not establish how much of an applied amount crosses intact human skin, or in what state.

Is GHK-Cu injected in studies?

Part of the literature is animal work given parenterally and dosed per kilogram of animal. That is an experimental design choice, not a recommendation, and the figures do not convert to a human amount.

Does PhaseOne provide dosing or route guidance?

No. For any compound in the range we supply powder with a batch purity figure. Protocol decisions belong to the researcher, and anything involving a person belongs to a prescriber.

Is a GHK-Cu serum better than a vial?

They are not on the same scale, so better does not apply. A serum is a finished cosmetic product. A vial is laboratory material. Which is appropriate depends entirely on what you are doing.

How does a 1% serum compare to 10mg per ml?

It does not compare. A percentage is a share of a whole formulation; mg per ml is mass in a volume that you set when reconstituting. Neither is a delivered amount.

What concentration do I get from a GHK-Cu vial?

Whatever you set. Concentration is a function of the vial mass and how much bacteriostatic water you add, which the reconstitution guide covers.

Why is a serum percentage not enough information?

Because it tells you the proportion in the mixture and nothing about purity, stability, how much is still intact or how much is delivered. A vial at least carries a batch purity figure.

What compounds are in the cosmetic category?

GHK-Cu and Melanotan II, plus the GLOW and KLOW blends which are built on GHK-Cu alongside regenerative-category compounds.

Do GHK-Cu and Melanotan II work the same way?

No. GHK-Cu's activity is copper-dependent. Melanotan II is an alpha-MSH analogue studied at MC1R and MC4R. They share no receptor or pathway.

Is Melanotan II only about pigmentation?

No. Its MC4R activity is a separate dimension of its profile, unrelated to any pigmentation question, and it is a defining part of the compound rather than a footnote.

Are GHK-Cu and Melanotan II in the same regulatory position?

No. Melanotan II is Schedule 4 in the Poisons Standard. GHK-Cu has no entry. The legality guide sets out what each of those means.

What is in GLOW and KLOW?

GLOW is BPC-157, TB-500 and GHK-Cu in a 70mg vial. KLOW adds KPV, in an 80mg vial.

Why would a blend be a problem for a protocol?

Because an outcome cannot be attributed to any single component. A blend suits a design that wants the components together and complicates one that needs attribution.

Why is GHK-Cu light sensitive?

Its activity depends on copper staying coordinated to the tripeptide, and that complex is the light-sensitive part. Keep vials and reconstituted solution dark.

Does GHK-Cu need different storage from Melanotan II?

It needs the extra light protection, because of the copper complex. Melanotan II does not carry that particular constraint.

Why does GHK-Cu appear in the regenerative category too?

Because the same copper-dependent mechanism is studied from a skin angle and a broader tissue angle. One mechanism, two research framings, not two mechanisms.

What purity does PhaseOne state for this category?

≥99% HPLC purity, tested independently batch by batch, with results published in the public COA library.

Where can I buy research-grade GHK-Cu in Australia?

PhaseOne supplies it as lyophilised powder in 50mg and 100mg vials, shipped Australia-wide from Sydney, for laboratory research only.

Disclaimer

All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications. Nothing on this page is administration, dosing or application guidance.

Written by
PhaseOne Research Team
Last updated 9 October 2026

Contact us